1. Eli Lilly's Weight Loss Pill Launch: 1,400 Prescriptions in First Week Signals Strong Demand
Eli Lilly's new weight loss pill, Mounjaro, has reportedly generated nearly 1,400 prescriptions in its first week of commercial availability. This early data point provides a tangible, if initial, signal of the intense market demand for next-generation GLP-1 drugs, moving beyond analyst projections to real-world uptake...